These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6276829)

  • 21. No change in rat cerebral cortex calmodulin content following chronic treatment with lithium, reserpine, imipramine, and lithium combined with reserpine or imipramine.
    Andersen PH; Geisler A; Klysner R
    Acta Pharmacol Toxicol (Copenh); 1984 May; 54(5):394-9. PubMed ID: 6087616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different mechanisms of beta-adrenoceptor down-regulation by chronic imipramine and electroconvulsive treatment: possible role for protein kinase C.
    Nalepa I; Vetulani J
    J Neurochem; 1991 Sep; 57(3):904-10. PubMed ID: 1650396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of imipramine treatment on brain serotonin receptors and beta-adrenoceptors and on pineal beta-adrenergic function in adult and aged rats.
    Friedman E; Cooper T; Yocca F
    Eur J Pharmacol; 1986 Apr; 123(3):351-6. PubMed ID: 3013651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat.
    Ordway GA; O'Donnell JM; Frazer A
    J Pharmacol Exp Ther; 1987 Apr; 241(1):187-95. PubMed ID: 3033200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo or in vitro exposure to imipramine reduces alpha 2-adrenoceptor-mediated inhibition of cyclic AMP production in rat brain cerebral cortical slices.
    Nomura S; Duman RS; Enna SJ
    Brain Res; 1987 Apr; 410(1):195-8. PubMed ID: 2884021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine.
    Swann AC
    Neuropharmacology; 1988 Mar; 27(3):261-7. PubMed ID: 2836750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective increases in the density of cerebellar beta-1-adrenergic receptors.
    Wolfe BB; Minneman KP; Molinoff PB
    Brain Res; 1982 Feb; 234(2):474-9. PubMed ID: 6277437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strain differences in changes in some parameters of cerebral cortical adrenergic system following chronic imipramine administration to rats.
    Vetulani J; Nalepa I; Popik P
    Pol J Pharmacol Pharm; 1991; 43(3):187-95. PubMed ID: 1660132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain.
    Devaki R; Shankar Rao S; Nadgir SM
    J Psychiatry Neurosci; 2006 Jul; 31(4):246-52. PubMed ID: 16862242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of beta-adrenergic receptors in normal and mutant mouse cerebellum.
    East JM; Dutton GR
    Dev Neurosci; 1982; 5(2-3):117-24. PubMed ID: 6290171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization of beta-adrenoceptors following repeated injections of 2-substituted 4-phenylquinolines.
    Alhaider AA
    J Pharm Pharmacol; 1987 Sep; 39(9):746-7. PubMed ID: 2890745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The (-)-deprenyl actions on beta-adrenergic receptors require the integrity of brain serotonergic axon terminals.
    Gandolfi O; Barbaccia ML; Costa E
    Eur J Pharmacol; 1984 Apr; 100(2):233-7. PubMed ID: 6329776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Adrenergic receptor regulation and antidepressants: the influence of adrenocorticotropin.
    Enna SJ; Duman RS
    J Neural Transm; 1983; 57(4):297-307. PubMed ID: 6317800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic thyroxine treatment of rats down-regulates the noradrenergic cyclic AMP generating system in cerebral cortex.
    Schmidt BH; Schultz JE
    J Pharmacol Exp Ther; 1985 May; 233(2):466-72. PubMed ID: 2987486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: evidence for mediation through the beta-adrenoceptor-coupled cyclic AMP system.
    Sessler FM; Mouradian RD; Cheng JT; Yeh HH; Liu WM; Waterhouse BD
    Brain Res; 1989 Oct; 499(1):27-38. PubMed ID: 2478258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imipramine and tetrabenazine: effects on monoamine receptor binding sites and phosphoinositide hydrolysis.
    Butler PD; Edwards E; Barkai AI
    Eur J Pharmacol; 1989 Jan; 160(1):93-100. PubMed ID: 2540994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothyroidism elicits electrophysiological noradrenergic subsensitivity in rat cerebellum.
    Marwaha J; Prasad KN
    Science; 1981 Nov; 214(4521):675-7. PubMed ID: 6270792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium does not prevent ECS-induced decreases in beta-adrenergic receptors.
    Birmaher B; Lerer B; Belmaker RH
    Psychopharmacology (Berl); 1982; 78(2):190-1. PubMed ID: 6294719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Norepinephrine enhancement of inhibitory synaptic mechanisms in cerebellum and cerebral cortex: mediation by beta adrenergic receptors.
    Waterhouse BD; Moises HC; Yeh HH; Woodward DJ
    J Pharmacol Exp Ther; 1982 May; 221(2):495-506. PubMed ID: 6281417
    [No Abstract]   [Full Text] [Related]  

  • 40. Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments.
    Vetulani J; Antkiewicz-Michaluk L; Rokosz-Pelc A; Pilc A
    Pol J Pharmacol Pharm; 1984; 36(2-3):231-48. PubMed ID: 6089158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.